ArticleMolecular therapy : the journal of the American Society of Gene Therapy2023
Bypassing pre-existing antibodies extends the applicability of AAV-based retinal therapies.
Hannah F Hu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.